Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 64 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Endometrial Neoplasms 6 Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Hereditary Sensory and Autonomic Neuropathies 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Breast Cancer 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms by Site 3 Colorectal Neoplasms 3 Breast Diseases 3 Small Cell Lung Carcinoma 2 Melanoma 2 Locally Advanced (Inoperable) or Metastatic Breast Cancer 2 Head and Neck Neoplasms 2 Uterine Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Stomach Neoplasms 1 Spinocerebellar Degenerations 1 Salivary Gland Neoplasms 1 Recurrence 1 Multiple Endocrine Neoplasia Type 1 1 Lung Neoplasms 1 Locoregional Recurrence 1

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Locoregional Recurrence × Fulvestrant × 90 days × Clear all

NCT05467891 2026-04-08

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡